Quantcast

Latest Anti-diabetic drugs Stories

2015-02-03 08:32:06

CARLSBAD, Calif., Feb. 3, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.

2015-01-16 08:25:17

JERUSALEM, January 16, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc.

2014-12-21 23:00:57

Hundreds of Byetta lawsuits and other product liability claims involving incretin mimetic diabetes drugs are currently pending in the federal litigation underway in California. New

2014-12-10 12:28:36

DALLAS, December 10, 2014 /PRNewswire/ -- ReportsnReports.com adds Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes

2014-12-07 23:01:20

The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer caused by incretin

2014-12-02 12:31:26

The Lack of Reimbursement for DPP-IV Inhibitors and GLP-1 Analogues Hinders Their Uptake Among Chinese Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Dec.

2014-12-01 23:00:55

The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer caused by incretin


Word of the Day
dynamitard
  • A political dynamiter.
The word 'dynamitard' is related to 'dynamite', which comes from a Greek root meaning 'power' and was coined by Alfred Nobel.